ASTRAZEN.BOASTRAZEN.BOBSE
Loading
SG&A Expense Growth TrendStable
Percentile Rank62
3Y CAGR-14.1%
5Y CAGR+2.5%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-14.1%/yr
Quarterly compound
5Y CAGR
+2.5%/yr
Recent deceleration
Percentile
P62
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
4 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q4 2025 | 27.95% |
| Q3 2025 | 27.20% |
| Q2 2025 | 0.00% |
| Q1 2025 | -3.17% |
| Q4 2024 | -75.43% |
| Q3 2024 | 59.47% |
| Q2 2024 | -6.80% |
| Q1 2024 | 119.67% |
| Q4 2023 | 86.00% |
| Q3 2023 | -75.67% |
| Q2 2023 | 24.83% |
| Q1 2023 | 141.47% |
| Q4 2022 | 44.03% |
| Q3 2022 | 34.44% |
| Q2 2022 | -78.70% |
| Q1 2022 | 248.68% |
| Q4 2021 | 46.95% |
| Q3 2021 | -4.34% |
| Q2 2021 | -78.59% |
| Q1 2021 | 235.23% |
| Q4 2020 | 24.73% |
| Q3 2020 | 24.35% |
| Q2 2020 | -77.14% |
| Q1 2020 | 245.56% |
| Q4 2019 | -16.52% |
| Q3 2019 | -17.50% |
| Q2 2019 | -68.29% |
| Q1 2019 | 224.29% |
| Q4 2018 | 41.33% |
| Q3 2018 | -83.70% |
| Q2 2018 | 81.28% |
| Q1 2018 | -35.89% |
| Q4 2017 | 304.09% |
| Q3 2017 | 28.72% |
| Q2 2017 | -63.29% |
| Q1 2017 | -43.05% |
| Q4 2016 | 8.77% |
| Q3 2016 | -5.13% |
| Q2 2016 | 9.36% |
| Q1 2016 | -4.58% |